Stifel Financial Corp Boosts Stake in Haleon plc (NYSE:HLN)

Stifel Financial Corp increased its holdings in shares of Haleon plc (NYSE:HLN - Free Report) by 4.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,033,298 shares of the company's stock after purchasing an additional 88,749 shares during the period. Stifel Financial Corp's holdings in Haleon were worth $19,398,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the stock. Addison Advisors LLC grew its stake in shares of Haleon by 28.7% in the fourth quarter. Addison Advisors LLC now owns 4,954 shares of the company's stock valued at $47,000 after buying an additional 1,106 shares in the last quarter. Synovus Financial Corp raised its holdings in Haleon by 0.8% in the 3rd quarter. Synovus Financial Corp now owns 148,834 shares of the company's stock valued at $1,575,000 after acquiring an additional 1,216 shares in the last quarter. Haverford Trust Co lifted its position in Haleon by 5.0% during the fourth quarter. Haverford Trust Co now owns 25,842 shares of the company's stock worth $247,000 after purchasing an additional 1,233 shares during the period. Bessemer Group Inc. boosted its position in shares of Haleon by 5.9% during the 4th quarter. Bessemer Group Inc. now owns 22,301 shares of the company's stock worth $212,000 after acquiring an additional 1,236 shares in the last quarter. Finally, United Capital Financial Advisors LLC increased its stake in Haleon by 3.5% in the fourth quarter. United Capital Financial Advisors LLC now owns 37,475 shares of the company's stock valued at $358,000 after acquiring an additional 1,266 shares during the last quarter. Institutional investors own 6.67% of the company's stock.

Haleon Stock Up 1.7 %

Shares of NYSE:HLN traded up $0.18 during midday trading on Thursday, hitting $10.33. 8,530,609 shares of the company's stock were exchanged, compared to its average volume of 7,479,954. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The stock has a 50 day moving average price of $10.15 and a 200-day moving average price of $9.81. The company has a market cap of $46.59 billion, a PE ratio of 30.37, a price-to-earnings-growth ratio of 2.82 and a beta of 0.24. Haleon plc has a 12 month low of $8.12 and a 12 month high of $10.80.

Haleon (NYSE:HLN - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. The business had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. On average, sell-side analysts anticipate that Haleon plc will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The business also recently disclosed a -- dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be paid a dividend of $0.1166 per share. This represents a dividend yield of 1.6%. This is a positive change from Haleon's previous -- dividend of $0.05. The ex-dividend date is Friday, April 25th. Haleon's payout ratio is presently 58.97%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Haleon in a research note on Monday, March 3rd. Sanford C. Bernstein lowered shares of Haleon from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 8th. Hsbc Global Res lowered shares of Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. HSBC reissued a "hold" rating on shares of Haleon in a research note on Wednesday, March 5th. Finally, Morgan Stanley downgraded shares of Haleon from an "overweight" rating to an "equal weight" rating in a research note on Friday, January 10th. Six analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Haleon has an average rating of "Hold" and a consensus price target of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.